At a recent financial conference, Prenetics Global's CEO discussed the company's strong growth trajectory, particularly highlighting the IM8 product line.
The CEO provided revenue guidance for the upcoming period, estimating between $180 million and $200 million.
This guidance reflects the anticipated impact of IM8's breakout growth on the company's overall performance and infrastructure capacity.